Market Highlights: Postherpetic neuralgia affects the nerve fibers and skin. PHN is nerve pain that persists for more than 30 days after the reactivation of herpes zoster. The nerve pain is a result of damage to the peripheral nerve. The postherpetic neuralgia treatment market is expected to grow in the future due to an increase in the prevalence of postherpetic neuralgia and availability of advancements in treatment Techniques. The market study is being classified by Type (Patches (Capsaicin Skin Patches and Lidocaine Skin Patches), Drugs and Opioids), by Application (Hospitals, Clinics and Others) and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Key Players: The prominent players in the Post Herpetic Neuralgia Treatment are Pfizer (United States), Teva Pharmaceutical Industries Ltd (Isreal), Mylan N.V. (United States), Endo (Ireland), Daiichi Sankyo (Japan), Acorda Therapeutics (United States), Purdue Pharma L.P (United States), Teikoku Pharma USA, Inc.(United States) and Janssen Pharmaceuticals, Inc. (Belgium).
Key Questions Answered in the Report What will the Post Herpetic Neuralgia Treatment Market size and the growth rate be in Future? What are the key factors driving the Post Herpetic Neuralgia Treatment Market? What are the key market trends and macro-economic impacting the growth of the Post Herpetic Neuralgia Treatment Market? What are the challenges to market growth? Who are the key vendors in the Post Herpetic Neuralgia Treatment Market? What are the market opportunities and threats faced by the vendors in the Post Herpetic Neuralgia Treatment Market? Trending factors influencing the market shares of the Players. What are the key outcomes of the five forces analysis of the Post Herpetic Neuralgia Treatment Market?
Research Methodology: The top-down and bottom-up approaches are used to estimate and validate the size of the Global Post Herpetic Neuralgia Treatment market. In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Post Herpetic Neuralgia Treatment market. In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc. Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Post Herpetic Neuralgia Treatment Providers, Healthcare Industry, Research Institutes, Government Agencies, Medical Research Laboratories and Others. This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth etc. Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.